Skip to main content
HCPCS J1100 · Level II · Part B drug

J1100: dexamethasone sodium phosphate, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1100

Billing unit
1 MG
Dexamethasone sodium phos
ASP payment limit
$0.099
October 2026; +16.5% vs July 2026
Practitioner MUE
120
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
2
8 states

TL;DR

HCPCS J1100 is the Level II code for Injection, dexamethasone sodium phosphate, 1 mg, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $0.099 per billing unit, up 16.5% from July 2026. The practitioner MUE allows up to 120 units per date of service (MAI 3), so a full 120-unit day is $11.88 at the current limit. Under OPPS it carries status indicator N. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. The ASP crosswalk maps 54 NDCs to it, sold as Dexamethasone Sodium Phosphate by Henry Schein Inc., Hikma Pharmaceuticals USA Inc., Sagent Pharmaceuticals. 2 Medicare coverage articles list the code across 5 states plus DC and 2 territories, including A57114.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1100 at $0.099 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.085 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1100
QuarterPayment limitPerCoinsurance
October 2026$0.0991 MG20%
July 2026$0.0851 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 54 NDCs from 12 labelers to J1100. Report the NDC in the claim's drug segment and bill the number of J1100 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J1100
NDCDrug nameLabelerPackage sizeBilling units / package
00404-9795-30Dexamethasone Sodium PhosphateHenry Schein Inc.30 × 1120
00404-9805-05Dexamethasone Sodium PhosphateHenry Schein Inc.5 × 120
00404-9841-05Dexamethasone Sodium PhosphateHenry Schein Inc.5 × 120
00404-9842-10Dexamethasone Sodium PhosphateHenry Schein Inc.10 × 1100
00404-9843-30Dexamethasone Sodium PhosphateHenry Schein Inc.30 × 1120
00641-0367-25Dexamethasone Sodium PhosphateHikma Pharmaceuticals USA Inc.1 × 25250
00641-6145-25Dexamethasone Sodium PhosphateHikma Pharmaceuticals USA Inc.1 × 25100
00641-6146-10Dexamethasone Sodium PhosphateHikma Pharmaceuticals USA Inc.5 × 10200
00641-6146-25Dexamethasone Sodium PhosphateHikma Pharmaceuticals USA Inc.5 × 25500
25021-0052-01Dexamethasone Sodium PhosphateSagent Pharmaceuticals1 × 25100
25021-0052-05Dexamethasone Sodium PhosphateSagent Pharmaceuticals5 × 25500
25021-0053-01Dexamethasone Sodium PhosphateSagent Pharmaceuticals1 × 25250
50090-0414-00Dexamethasone Sodium PhosphateA-S Medication Solutions30 × 1120
50090-0627-02Dexamethasone Sodium PhosphateA-S Medication Solutions5 × 240
50090-1922-00Dexamethasone Sodium PhosphateA-S Medication Solutions1 × 25100
50090-1922-01Dexamethasone Sodium PhosphateA-S Medication Solutions1 × 14
50090-2313-02Dexamethasone Sodium PhosphateA-S Medication Solutions5 × 25500
50090-3300-00Dexamethasone Sodium PhosphateA-S Medication Solutions30 × 253000
50090-3541-00Dexamethasone Sodium PhosphateA-S Medication Solutions1 × 25250
51662-1297-01Dexamethasone Sodium PhosphateHF Acquisition Co. LLC, DBA HealthFirst5 × 120
51662-1297-03Dexamethasone Sodium PhosphateHF Acquisition Co. LLC, DBA HealthFirst5 × 25500
51662-1343-01Dexamethasone Sodium PhosphateHF Acquisition Co. LLC, DBA HealthFirst1 × 110
51662-1343-03Dexamethasone Sodium PhosphateHF Acquisition Co. LLC, DBA HealthFirst1 × 25250
51662-1541-01Dexamethasone Sodium PhosphateHF Acquisition Co. LLC, DBA HealthFirst10 × 1100
51662-1660-01Dexamethasone Sodium PhosphateHF Acquisition Co. LLC, DBA HealthFirst5 × 120
51662-1660-03Dexamethasone Sodium PhosphateHF Acquisition Co. LLC, DBA HealthFirst5 × 10200
55150-0239-30Dexamethasone Sodium PhosphateEugia US LLC30 × 253000
55150-0304-25Dexamethasone Sodium PhosphateEugia US LLC1 × 25250
55150-0305-10Dexamethasone Sodium PhosphateEugia US LLC10 × 101000
63323-0165-01Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC1 × 25100
63323-0165-05Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC5 × 25500
63323-0165-16Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC1 × 25100
63323-0165-26Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC5 × 25500
63323-0165-30Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC30 × 1120
63323-0506-01Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC1 × 25250
63323-0506-16Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC1 × 25250
63323-0516-10Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC10 × 101000
67457-0418-05Dexamethasone Sodium PhosphateMylan Institutional LLC5 × 25500
67457-0419-01Dexamethasone Sodium PhosphateMylan Institutional LLC1 × 25100
67457-0420-10Dexamethasone Sodium PhosphateMylan Institutional LLC10 × 101000
67457-0421-30Dexamethasone Sodium PhosphateMylan Institutional LLC30 × 253000
67457-0422-54Dexamethasone Sodium PhosphateMylan Institutional LLC5 × 25500
67457-0423-12Dexamethasone Sodium PhosphateMylan Institutional LLC1 × 25100
67457-0483-10Dexamethasone Sodium PhosphateMylan Institutional LLC10 × 101000
67457-0484-30Dexamethasone Sodium PhosphateMylan Institutional LLC30 × 253000
70069-0021-25Dexamethasone Sodium PhosphateSomerset Pharma, LLC1 × 25250
70069-0025-10Dexamethasone Sodium PhosphateSomerset Pharma, LLC10 × 101000
72485-0118-25Dexamethasone Sodium PhosphateArmas Pharmaceuticals Inc.1 × 25250
72572-0120-25Dexamethasone Sodium PhosphateCivica, Inc.1 × 25100
72572-0122-25Dexamethasone Sodium PhosphateCivica, Inc.1 × 25250
76045-0109-10Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC1 × 24240
76045-0210-10Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC1 × 2496
76045-0212-10Dexamethasone Sodium PhosphateFreseniUS Kabi USA, LLC1 × 24240
81565-0202-02Dexamethasone Sodium PhosphatePhlow Corporation1 × 25100

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J1100. For practitioners the limit is 120 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1100 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services1203 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital1203 Date of Service Edit: ClinicalClinical: Data
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J1100 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1100 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1100 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1100 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

2 current Medicare Administrative Contractor articles list J1100 in their HCPCS tables, covering 8 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J1100
ArticleTitleContractor(s)StatesRelated LCD
A57114Billing and Coding: Trigger Point InjectionsFirst Coast Service Options, Inc.FL PR VIL33912
A57751Billing and Coding: Trigger Point InjectionsNovitas Solutions, Inc.DC DE MD NJ PAL35010

Diagnoses Medicare contractors cover for J1100

The 2 articles that list J1100 tie their diagnosis groups to other procedure codes, so no covered ICD-10-CM list is attributed to J1100 itself; the diagnosis has to fit the group written for the procedure billed with the drug. See A57114, A57751.

Local coverage policies that list J1100

2 active Local Coverage Determinations list J1100 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1100 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1100 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J1100 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1100

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1100

What does HCPCS code J1100 describe?

J1100 is defined by CMS as "Injection, dexamethasone sodium phosphate, 1 mg". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1100 a CPT code?

No. J1100 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as dexamethasone sodium phosphate; CPT codes are five-character codes maintained by the AMA. On a Part B claim J1100 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1100 in October 2026?

The ASP-based payment limit is $0.099 per 1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.085. Commercial payers use their own fee schedules.

How many units of J1100 can be billed per day?

The practitioner Medically Unlikely Edit is 120 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J1100?

The October 2026 ASP crosswalk lists 54 NDCs from 12 labelers: Dexamethasone Sodium Phosphate (Henry Schein Inc.); Dexamethasone Sodium Phosphate (Hikma Pharmaceuticals USA Inc.); Dexamethasone Sodium Phosphate (Sagent Pharmaceuticals); Dexamethasone Sodium Phosphate (A-S Medication Solutions). For example NDC 00404-9795-30 (package size 30) equals 120 billing units of J1100.

Does J1100 have NCCI bundling edits?

No active practitioner PTP pairs list J1100 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention J1100?

2 current Billing and Coding Articles in the Medicare Coverage Database list J1100, covering 5 states plus DC and 2 territories: A57114 (Billing and Coding: Trigger Point Injections); A57751 (Billing and Coding: Trigger Point Injections).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.